Navigation path

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece


   Infocentre

Published: 4 February 2016  
Related theme(s) and subtheme(s)
Health & life sciences
Research policyHorizon 2020
Special CollectionsCancer
Countries involved in the project described in the article
Belgium  |  Israel  |  Netherlands  |  Serbia  |  Spain  |  United Kingdom
Add to PDF "basket"

A portable device to detect the signs of cancer

A portable device to detect potential signs of cancer in a patient's urine is under development within the EU-funded research project GLAM. The project aims to speed up cancer diagnosis and monitoring, while making the process both less intrusive and less unpleasant.

Boy on the beach

© photopitu - fotolia.com

Biomarkers are substances or processes in the body that can indicate the presence of a disease. Most types of cancer biomarker analysis require test samples of body tissues or blood, which are then sent to a specialised lab for analysis. This process can be painful, take a long time and cost a lot of money.

GLAM’s researchers plan to develop a portable diagnostic device to detect cancer biomarkers in urine. The analysis will focus on cancers of the genital and urinary organs, but the researchers say GLAM’s technology will have the potential for further development – for analysis of other biofluid types and for the possible diagnosis and monitoring of other cancers and diseases.

The device will use photonic biosensors, a technology known to be highly sensitive and relatively simple to use. GLAM aims to develop the technology so that the biosensors are able to detect up to 10 different biomarkers from a small amount of urine.

“Most cancer biopsies must be analysed in specialised laboratories, which involves high costs and long waiting periods, as they require specialised personnel and equipment,” says project coordinator Izabel Alfany of Acondicionamiento Tarrasense Associacion in Spain. “There is therefore a real need and urgency to have new devices that provide diagnosis, prognosis, and data monitoring faster and with exceptional ultra-sensitivity.”

Project details

  • Project acronym: GLAM
  • Participants: Spain (Coordinator), Netherlands, Israel, Serbia, Belgium, UK
  • FP7 Proj. N° 634928
  • Total costs: € 4 835 584
  • EU contribution: € 4 835 584
  • Duration: May 2015 - May 2019

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also
Project Website
Project information on CORDIS






  Top   Research Information Center
 
Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece